PackTalk is a blog for the Healthcare Packaging Industry

MedTech Conference Hot Topics


Published on November 9, 2020

AdvaMed’s conference takes on medtech’s need to actively increase diversity and inclusion and fight racism, now.

If there is one thing we’ve learned in 2020, it is that our industry, along with others, must take a stand against racial injustice. AdvaMed’s Virtual MedTech Conference did just that, as part of its MedTech Unfiltered presentation and other conference segments, as well.

AdvaMed readily admitted that they do not have a solution for the social tensions across the nation, but pledged to listen and act. The tenor of the conversation was encouraging and unifying, as leaders from various firms openly discussed what Danaher CEO, Ranier Blair, aptly labeled “difficult truths.” By focusing on humility, empathy and desire to be change makers, speakers challenged the entire medtech industry to become a positive example for other sectors, through education and action.

MD&DI shares breaking insights in this article, including a point we found striking: what’s behind the lack of diversity in clinical research data? Indeed, looking for opportunities to improve in unexpected places can help all of us rally to go forward for good.

Read more


Comments (0)

Related Articles

One Doctor’s Request for Sustainable Change in Asia

September 17, 2021

152 kilograms. 4500 tonnes. 134 hectares. No matter how you say it, it’s not positive or sustainable. These numbers reflect the amount of medical waste from just one surgery, in a study from four hospitals over three months in New Zealand. 152 kilograms is...

Learn More

Cracking the Age Old Dilemma: Compliance or Quality?

September 17, 2021

I recently read an article from Medtech Insights on how device giants Stryker and Baxter embrace a quality first culture – and yield positive results. In the article, Stryker’s Medha Trivedi, the company’s senior director of global quality and operations said...

Learn More

Power to the PDUFA

September 17, 2021

The Prescription Drug User Fee Act was passed into law by Congress in 1992. The PDUFA implemented a fee-based framework for New Drug Applications and Biologics License Applications. One of its primary objectives was to provide funding to speed up the glacial...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.